• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FISHER & PAYKEL HEALTHCARE LTD AIRVO 2 HUMIDIFIER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FISHER & PAYKEL HEALTHCARE LTD AIRVO 2 HUMIDIFIER Back to Search Results
Model Number PT101
Device Problems No Flow (2991); Insufficient Information (3190)
Patient Problem Low Oxygen Saturation (2477)
Event Date 08/22/2022
Event Type  Injury  
Manufacturer Narrative
(b)(4).Fisher & paykel healthcare (f&p) is currently in the process of obtaining further information regarding the reported event.We will provide a follow up report upon completion of our investigation.Product background: the pt101 airvo 2 humidifier (airvo 2) device is an active humidifier with integrated flow generator that delivers high flow warmed and humidified respiratory gases to spontaneously breathing patients through a variety of patient interfaces.It's intended use is for the treatment of spontaneously breathing patients who would benefit from receiving high flow warmed and humidified respiratory gases.The airvo 2 device should not be used for life support purposes, and appropriate patient monitoring must be used at all times.
 
Event Description
A healthcare facility in the united kingdom reported via a fisher & paykel healthcare (f&p) field representative that there was no flow detected from a pt101 airvo 2 humidifier in use with nasal prongs.The healthcare facility reported that the patient's saturation declined, and that the patient became cyanotic and had an apnoeic episode.The patient required respiratory resuscitation with a bag and mask.There were no further patient consequences reported.The healthcare facility further reported that the patient was critically ill and was having breathing difficulty with low saturations prior to the event.In the healthcare facility's incident report the reported injury was deemed by the healthcare facility as being low-minimal harm.It was further reported by the healthcare facility that the subject airvo was tested, and no fault was found with the device.The device was put back into service by the healthcare facility.
 
Event Description
A healthcare facility in the united kingdom reported via a fisher & paykel healthcare (f&p) field representative that there was no flow detected from a pt101 airvo 2 humidifier in use with nasal prongs.The healthcare facility reported that the patient's saturation declined, and that the patient became cyanotic and had an apnoeic episode.The patient required respiratory resuscitation with a bag and mask.There were no further patient consequences reported.The healthcare facility further reported that the patient was critically ill and was having breathing difficulty with low saturations prior to the event.In the healthcare facility's incident report the reported injury was deemed by the healthcare facility as being low-minimal harm.It was further reported by the healthcare facility that the subject airvo was tested, and no fault was found with the device.The device was put back into service by the healthcare facility.
 
Manufacturer Narrative
(b)(4).Product background: the pt101 airvo 2 humidifier (airvo 2) device is an active humidifier with integrated flow generator that delivers high flow warmed and humidified respiratory gases to spontaneously breathing patients through a variety of patient interfaces.Its intended use is for the treatment of spontaneously breathing patients who would benefit from receiving high flow warmed and humidified respiratory gases.The airvo 2 device should not be used for life support purposes, and appropriate patient monitoring must be used at all times.Method: the complaint airvo 2 was not returned to fisher & paykel healthcare (f&p) for evaluation.Our investigation is based on the information provided by the customer and our knowledge of the product.Results: the healthcare facility reported that there was no flow detected from the airvo 2.Testing by the healthcare facility reported that there was no fault found with the complaint airvo 2.The device was returned to service by the healthcare facility.It was also reported that the patient required respiratory resuscitation with a bag and mask.The healthcare facility further reported that the patient was critically ill and was having breathing difficulty with low saturations prior to the event.No further patient consequences were reported.Conclusion: without the return of the subject device, we are unable to confirm the cause of the reported event.The healthcare facility reported that there was no fault found with the subject device.During the manufacturing process, quality control measures ensure each manufactured airvo 2 meets specification and are performed at the end of the final assembly process on 100% of manufactured units.Any unit that fails any of these tests will be rejected.The subject airvo 2 would have met the required specifications.The pt101 airvo 2 humidifier user manual states that the "airvo 2 is for the treatment of spontaneously breathing patients who would benefit from receiving high-flow, warmed and humidified respiratory gases" and "use continuous oxygen monitoring on patients who would desaturate significantly in the event of disruption to their oxygen supply." additionally, the user manual also warns the user: the unit is not intended for life support.Appropriate patient monitoring must be used at all times.Loss of therapy will occur if power is lost.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AIRVO 2 HUMIDIFIER
Type of Device
AIRVO 2 HUMIDIFIER
Manufacturer (Section D)
FISHER & PAYKEL HEALTHCARE LTD
15 maurice paykel place
east tamaki
auckland, 2013
NZ  2013
Manufacturer (Section G)
FISHER & PAYKEL HEALTHCARE LTD
15 maurice paykel place
east tamaki
auckland, 2013
NZ   2013
Manufacturer Contact
faranak gomarooni
17400 laguna canyon road
suite 300
irvine, CA 92618
9494534002
MDR Report Key15452428
MDR Text Key300211561
Report Number9611451-2022-00865
Device Sequence Number1
Product Code BTT
UDI-Device Identifier09420012422354
UDI-Public(01)09420012422354(10)2101101133(11)200504
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K131895
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Biomedical Engineer
Type of Report Initial,Followup
Report Date 08/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPT101
Device Catalogue NumberPT101
Device Lot Number2101101133
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/22/2022
Initial Date FDA Received09/19/2022
Supplement Dates Manufacturer Received11/10/2022
Supplement Dates FDA Received11/17/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/04/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-